Facebook Twitter

Johnson & Johnson COVID-19 vaccine recommended for authorization by FDA panel

A FDA panel of advisors recommended that Johnson & Johnson’s single shot should be approved

SHARE Johnson & Johnson COVID-19 vaccine recommended for authorization by FDA panel
This September 2020 photo provided by Johnson & Johnson shows the investigational Janssen COVID-19 vaccine. Johnson & Johnson’s long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.

This September 2020 photo provided by Johnson & Johnson shows the investigational Janssen COVID-19 vaccine.

Cheryl Gerber, Johnson & Johnson via AP

Advisors from the Food and Drug Administration announced Friday that the Johnson & Johnson COVID-19 vaccine would receive emergency use authorization, CNN reports.

The vaccine would become available to all Americans if the FDA accepts the recommendations, according to CNN.

Per CNBC, the FDA often follows the recommendations from the advisory committee. Previously, the FDA authorized vaccines from Pfizer and Moderna.

  • “If J&J’s follows the pattern, a third vaccine could be authorized on Saturday,” per CNBC.

Flashback

An analysis from the Food and Drug Administration found the Johnson & Johnson single-dose COVID-19 vaccine is safe and effective, The Wall Street Journal reports.

  • The analysis said that the J&J vaccine is 66.1% effective in preventing moderate to severe symptoms of the novel coronavirus, according to The Wall Street Journal.
  • There were no deaths among those who received the vaccine, The Wall Street Journal reports.

Dr. Anthony Fauci, one of the country’s top infectious disease experts, told the “Today” show that the news that Johnson & Johnson’s vaccine is safe is “nothing but good news.”

  • “When you have a company like Johnson & Johnson that has a very good track record with pharmaceuticals, to have them be in the mix with the other two is nothing but good news.”